Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
International Journal of Antimicrobial Agents 33: 143148
The stakes are high on both sides: for patients who depend on these treatments, and for providers who face potential enforcement risk if they continue prescribing compounds that ultimately are not approved for the 503A Bulks List
393 Another example involves FeO-based hollow multishelled structures (HoMS), which enable temporally controlled sequential release of cisplatin and pemetrexed (MTA) within the TME
Presented for research literature review only Taniguchi N (1988)
Here is what we know, what we do not know, and where the gaps are
US$ 26.72
US$ 21.61
.png?ver=V_XikP92lILtNXWLnvc1tA%3D%3D&tx=w_842)
US$ 28.27
US$ 23.84
US$ 29.64
US$ 23.20
